CLINICAL_TRIALS
trial_result
· 2025-07-17
Clinical Trial Update: Safety and Tolerability of PRO-185 [Phase 1]
Summary
Phase 1 safety and tolerability study of PRO-185 for conjunctival hyperemia completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Hyperemia Eye | Phase 1 | Status: COMPLETED | Results posted: 2025-07-17